Back To Rising Leaders Gallery
Even though the industry’s knowledge of biology is expanding, drug development timelines and costs continue to increase while the chances of clinical success rates decrease. The average cost to bring...
Using a simulation-based drug discovery platform, Turbine is dramatically reshaping drug discovery and development, explains CEO and co-founder Szabolcs Nagy, a 2021 Rising Leader.
Back To Rising Leaders Gallery
Even though the industry’s knowledge of biology is expanding, drug development timelines and costs continue to increase while the chances of clinical success rates decrease. The average cost to bring...